Endo International | ENDP - Passività Correnti



Passività Correnti Cambiamento Data
AbbVie USD 42.1B 1.19B 2026-03
Amarin USD 179.64M 14.82M 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Coherus Biosciences USD 140.39M 231.91M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Heron Therapeutics USD 96.1M 6.39M 2025-12
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Ligand Pharmaceuticals USD 40.67M 3.22M 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Phibro Animal Health USD 281.87M 500K 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03
Zoetis USD 2.05B 182M 2026-03